Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Chabner

Showing results (31-40 of 139) with videos related to

Pageof 14
Sort By:
The Oncologist|July 2, 2013
In this issue: personalized medicineBruce A Chabner
The Oncologist|August 28, 2016
Understanding the Precision in "Precision Medicine"Bruce A Chabner
The Oncologist|January 21, 2010
Academia-pharma intersect: providing a broader perspective on drug development synergies between academia and industryBruce A Chabner
The Oncologist|March 30, 2021
Remembering JoséBruce A Chabner
The Oncologist|January 21, 2016
Reflections on 2015Bruce A Chabner
The Oncologist|April 19, 2002
The trust factorBruce A Chabner
The Oncologist|October 9, 2010
New results will change the paradigm for phase I trials and drug approvalBruce A Chabner
The Oncologist|April 2, 2008
Conflict of interest: in the eye of the beholder?Bruce A Chabner
Clinical Pharmacology and Therapeutics|November 15, 2017
Considerations About the Use of Biomarkers in Cancer Clinical TrialsBruce A Chabner
The Oncologist|June 1, 2004
The miracle of IressaBruce A Chabner
Pageof 14

Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
The Oncologist|July 2, 2013
In this issue: personalized medicineBruce A Chabner
The Oncologist|August 28, 2016
Understanding the Precision in "Precision Medicine"Bruce A Chabner
The Oncologist|January 21, 2010
Academia-pharma intersect: providing a broader perspective on drug development synergies between academia and industryBruce A Chabner
The Oncologist|March 30, 2021
Remembering JoséBruce A Chabner
The Oncologist|January 21, 2016
Reflections on 2015Bruce A Chabner
The Oncologist|April 19, 2002
The trust factorBruce A Chabner
The Oncologist|October 9, 2010
New results will change the paradigm for phase I trials and drug approvalBruce A Chabner
The Oncologist|April 2, 2008
Conflict of interest: in the eye of the beholder?Bruce A Chabner
Clinical Pharmacology and Therapeutics|November 15, 2017
Considerations About the Use of Biomarkers in Cancer Clinical TrialsBruce A Chabner
The Oncologist|June 1, 2004
The miracle of IressaBruce A Chabner
Pageof 14